Toshima-ku, Japan

Yoichiro Suga


 


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tokyo, JP (2015)
  • Toshima-ku, JP (2016)

Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yoichiro Suga: Innovator in Antimicrobial Pharmaceutical Compounds

Introduction

Yoichiro Suga is a notable inventor based in Toshima-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that exhibit antimicrobial properties. With a total of 2 patents, Suga's work focuses on innovative solutions to combat drug-resistant bacteria.

Latest Patents

Suga's latest patents include a hydroxamic acid derivative that serves as a pharmaceutical composition by inhibiting LpxC activity. This compound demonstrates potent antimicrobial activity against gram-negative bacteria, including drug-resistant strains. The hydroxamic acid derivative is represented by a specific general formula, which highlights its potential utility in medical applications.

Career Highlights

Throughout his career, Yoichiro Suga has worked with prominent companies such as Taisho Pharmaceutical Co., Ltd. and Toyama Chemical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Suga has collaborated with notable colleagues, including Hajime Takashima and Risa Tsuruta. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

In summary, Yoichiro Suga is a distinguished inventor whose work in antimicrobial pharmaceutical compounds has the potential to make a significant impact in the medical field. His innovative contributions continue to pave the way for advancements in combating drug-resistant bacteria.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…